FDA Inspection
American Red Cross Blood ServicesAmerican Red Cross Blood Services – FDA Inspection, Jun 8, 2023
Record Details
This FDA Inspection record concerns American Red Cross Blood Services, with an inspection on June 8, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · ce11abdb-dd30-4eed-98ff-e0103725c04e
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1208160
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of American Red Cross Blood Services
7| Date | Classification | Office | Project area |
|---|---|---|---|
| March 5, 2025 | Not classified | Atlanta District Office | |
| March 27, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 17, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 9, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 24, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for American Red Cross Blood Services
- FDA Inspection 1263330 - 2025-03-05
- FDA Inspection 1087334 - 2019-03-27
- FDA Inspection 1012871 - 2017-05-17
- FDA Inspection 929534 - 2015-06-09
- FDA Inspection 852329 - 2013-10-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.